Latest Breaking News On - Summary data - Page 1 : comparemela.com

JPX Market Innovation & Research: Addition Of New Data Datasets To Data Distribution Service J-Quants Pro For Corporate Users

<p><span>Today, May 24, 2024, JPXI has added three new data datasets to J-Quants Pro, which is a service that distributes financial data related to the Japanese market to corporate users in an easy-to-use manner.</span></p>

Monthly fees for internal use affiliated companyFrontier developmentMarket innovation research incTokyo stock exchangeJ quants proTrading volumeSingle entityAffiliated companyInternal useExcluding taxTrading outstandingIssues subjectDaily publicationSummary dataNew data datasetsData distribution servicej quants pro

OSHA releases 2023 injury and illness data

OSHA has published the 2023 data collected under its revised rules for annual injury and illness data submission.

United statesSummary dataCase detailCase detail dataInjury and illness ratesInjury dataInjury reportingIllness reporting

Drift Introduces Drift Engage to Help Businesses Capitalize on Anonymous Website Traffic

/PRNewswire/ Drift, the buyer experience and Conversational AI company, today announced Drift Engage, a first-to-market product powered by Lift AI, that.

United statesScott ernstDon simpsonCodeword agency forNew product usesIntent scoringPersonalize conversationsEvery site visitorDrift engageLive chatSummary dataConversational marketing

Korean GMP MFDS Requirements For On-Site And Document Audits of Medical Device Manufacturing Plants

Korean GMP MFDS Requirements For On-Site And Document Audits of Medical Device Manufacturing Plants
meddeviceonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from meddeviceonline.com Daily Mail and Mail on Sunday newspapers.

Kangkeun daniel leeMinistry of foodFreyr solutionsService delivery process of representative itemsKorea medical devices industry associationOrganization chart of the relevant manufacturing plantDevice industry developmentVitro diagnosticsQuality management systemDrug safetyConformity assessmentGood manufacturing practiceClassi medicalMedical deviceVitro diagnostics medical device actVitro diagnostics medical device

Precigen Announces Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T® Manufactured Overnight for Next Day Infusion in Relapsed or Refractory Acute Myeloid Leukemia Patients

– Single infusion of UltraCAR-T cells with or without lymphodepletion demonstrated robust expansion and persistence in blood and bone marrow – – PRGN-3006.

United statesDavida sallmanSteven harasymHelen sabzevariExchange commissionInternational prognostic scoring systemAmerican cancer societyPrecigen incDose levelBone marrowStable diseaseEuropean leukemianetObjective responsesControl rateResponse rateSummary data